Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd announced that it has entered into a share purchase agreement to issue not more than 16,021,361 A shares at an issue price of CNY 7.49 per share for the gross proceeds of CNY 119,999,994 ($16.60 million) on March 28, 2024. The transaction will include participation from returning investor, Wang Yiqing. The transaction has been approved by the shareholders of the company in the 6th Meeting of the company?s 4th Directorate and the 5th Meeting of the 4th Supervisory Board and is subject to the approvals of the Company?s Shareholders, the Shenzhen Stock Exchange, and the China Securities Regulatory Commission.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
10.48 CNY | +1.85% | +2.95% | -19.57% |
1st Jan change | Capi. | |
---|---|---|
-19.57% | 299M | |
+19.14% | 71.7B | |
-3.34% | 23.73B | |
+10.27% | 9.01B | |
+12.67% | 8.72B | |
-17.41% | 8.29B | |
+16.12% | 5B | |
+21.40% | 4.48B | |
-1.41% | 4.08B | |
-2.34% | 3.92B |
- Stock Market
- Equities
- 301126 Stock
- News Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd
- Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd announced that it expects to receive CNY 119.999994 million in funding